Body Mass Index as a Risk Factor for Prostate Cancer and Benign Prostate Hypertrophy: a Comparative Study at Three Reference Hospitals in Cameroon

Journal Title: RECENT ADVANCES IN PATHOLOGY AND LABORATORY MEDICINE - Year 2018, Vol 4, Issue 4

Abstract

Introduction: Prostate cancer (PCa) is the second most commonly diagnosed cancer and the sixth most common cause of cancer-related mortality among men worldwide. Obesity increases the prevalence and mortality of multiple cancers. Consequently, the relationship between obesity and cancer is receiving more and more attention. Objective: To evaluate the impact of body mass index (BMI) on prostate cancer detection and aggressiveness in Cameroonian population. Methodology: This was a comparative cross-sectional study carried out at the hospitals in Cameroon. The study included Cameroonians who underwent prostate biopsies during a 9-year period, from 2008 to 2016. We analysed the BMI, age, prostate volume, and PSA of patients with prostate cancer in comparison with patients with benign prostate tissue who underwent prostate biopsies. Data entry was performed using CSpro 6.3.2, analysis was done using SPSS version 23.0. Results: A total of 316 patients were included in our study, 158 PCa and 158 BPH. The patients had a mean age ± standard deviation of 67.8 ± 10.32 with a modal class of 61 and 70 years. In our study, the mean age ± SD of the PCa group (71.48 ± 8.96) was significantly greater than that of the BPH group (64.17 ± 10.31) (p<0.001).The PCa group had a mean BMI ± SD of 24.80 ± 4.07 while in the BPH group it was 24.49 ± 3.68, p = 0.472. Amongst the patients with high BMI, 71(52.2%) had prostate cancer while 65 (47.8%) had benign tissue. Amongst the patients with low BMI, 87(48.3%) had prostate cancer while 93 (51.4%) had benign tissue. The odds ratio was 1.168 with a 95% confidence interval of 0.748 to 1.823 (p>0.05). The median total PSA and the median PSA f/t ratio was significantly different in both groups (p<0.001 and p = 0.006). A Gleason score of 7 was the most frequent. Amongst those with a high BMI 77.5% (55) had a high Gleason score, which was significantly higher than the fraction in the low BMI group (60.9%) (53) (P = 0.026). Conclusion: We therefore conclude that BMI is not an independent risk factor for the development of prostate cancer; rather, it is associated with High Gleason PCa.

Authors and Affiliations

Sando Zacharie

Keywords

Related Articles

Recurrent Malignant Phyllodes Tumor of the Breast: A Rare Occurrence in a Young Nulliparous Woman

Phyllodes tumor of the breast is an uncommon fibroepithelial neoplasm and accounts for less than 1% of the primary breast neoplasms. The median age of its occurrence is 40–50 years. It has been sub-classified histologica...

Diagnostic Accuracy of USG-Guided FNAC in Gall Bladder Mass

Introduction: Malignancy of gall bladder is quite common. However, it cannot always be diagnosed only by clinical history and examination. We have evaluated diagnostic accuracy of USG-guided FNAC in GB mass.

Pathological Assessment of Response to Neoadjuvant Chemotherapy among Carcinoma Breast Patients in a Tertiary Level Hospital

Background: The role of the pathologist reporting a case of post-chemotherapy carcinoma breast involves not just looking for residual carcinoma, but also classifying the patient into a response category, based on histolo...

A Study to Correlate Endometrial Hyperplasia with Ovarian Stromal Change

Background: Endometrial hyperplasia in peri-menopausal age group is frequently encountered as a result of unopposed excess estrogen action, exact source of which is still debatable. Possible source is ovarian stroma. The...

Correlation between Modified Bloom Richardson Grade and Lymph Nodal Status in Infiltrating Ductal Type of Breast Carcinoma

Introduction: Breast cancer is one of the most common cancers in women. Among the various types, invasive ductal carcinomas (IDC), not otherwise specified (NOS) is the most common type. This study was conducted to descri...

Download PDF file
  • EP ID EP454961
  • DOI 10.24321/2454.8642.201817
  • Views 63
  • Downloads 0

How To Cite

Sando Zacharie (2018). Body Mass Index as a Risk Factor for Prostate Cancer and Benign Prostate Hypertrophy: a Comparative Study at Three Reference Hospitals in Cameroon. RECENT ADVANCES IN PATHOLOGY AND LABORATORY MEDICINE, 4(4), 18-22. https://europub.co.uk/articles/-A-454961